Articles

Elsevier,

Asian Journal of Psychiatry, Volume 101, November 2024

Update the demographic characteristics of patients with Alzheimer’s disease and their informants in eight Asian countries and compare them from 12 years prior.
Elsevier,

Neuropharmacology, Volume 259, 15 November 2024

This review explores using nanotechnology to enhance the delivery of neuroprotective phytochemicals from medicinal plants for Alzheimer's disease (AD), addressing issues of bioavailability, solubility, and blood-brain barrier penetration, and highlights the potential of nanocarriers to revolutionize neuroprotective drug delivery and improve patient outcomes.
Elsevier,

Brain Research, Volume 1843, 15 November 2024

This study developed a novel mouse model with tamoxifen-inducible knockout of the Gnpat gene, enabling late-onset plasmalogen deficiency to investigate its role in Alzheimer's disease. The model exhibited significant plasmalogen reduction and associated behavioral and nerve function changes, providing a valuable tool for future research on plasmalogen involvement in neurodegeneration and potential therapies.
Elsevier,

Neuropeptides, Volume 107, October 2024

Review on the study of active peptides in AD and PD, deals with role of inflamation, synaptic plasticity, and other learning, memory and cognitive functions related to AD
Elsevier,

Brain Research, Volume 1841, 15 October 2024

This study found that female 5XFAD mice exhibit early impairments in prefrontal-dependent cognitive functions and increased activity of prefrontal PV neurons, unlike their male counterparts. These findings suggest a potential mechanism for the higher risk of Alzheimer's disease in women, highlighting sex-specific early deregulation in the prefrontal cortex.
Elsevier,

Journal of Ethnopharmacology, Volume 333, 28 October 2024

This review investigates the connection between Type 2 Diabetes Mellitus and Alzheimer's disease, focusing on common mechanisms and the potential of traditional Indian herbs to manage both conditions. It also addresses the challenges and innovative strategies in delivering herbal formulations.
Elsevier,

Pharmacological Research, Volume 208, October 2024

The study explores the use of a novel gene delivery system, AAV-aMTD-Parkin, to enhance motor and cognitive functions in animal models of Parkinson’s and Alzheimer’s diseases. This system improves the delivery efficiency of therapeutic proteins, potentially offering a new treatment approach for these neurodegenerative disorders.
Elsevier,

Archaeological Research in Asia, Volume 39, September 2024

This research examines how indigenous archaeology and how the emergence of the first urban centers in the Mongolian steppe coincided with the establishment of the Uyghur Khaganate during the mid-eighth century CE.
Elsevier,

The Lancet Regional Health - Americas, Volume 37, September 2024

This paper supports SDG 3 with evidence of disparate effects of phased COVID-19 vaccine rollout on mental health across US populations, underlining the need for careful planning in future strategies for phased disease prevention and interventions.
Elsevier,

The Lancet Regional Health - Americas, Volume 37, September 2024

This viewpoint highlights the threat of gambling as an emerging public health issue in the American continent.

Pages